Compensation award — excluded from discretionary-purchase analysis.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
View the official recordSEC Form 4 — Statement of Changes in Beneficial OwnershipAll the details
Dates, kept separate
Transaction date
Feb 13, 2026
Reporting period
Not applicable
Filed with the SEC
Feb 17, 2026
CEOGrant / award
Context
Classification
grant award
Code A — grant or award
Planned / mechanical clue
Footnote references vesting of compensation awards
Only flagged when a footnote says so; never inferred
Source receipt
Record ID
0001193125-26-054514
Filed / recorded
Feb 17, 2026, 8:58 PM UTC
Added to OQRO
Oct 6, 2026, 7:14 PM UTC
Parser
form4-xml-v2
Data quality
Verified: identifiers matched exactly
Issuer
CHEMED CORP
Issuer CIK
19584
Ticker
CHE
Reporting person
Joel L Wherley
Relationship
Officer
Officer title
CEO - Vitas Healthcare
Security
Performance Stock Units
Table
Derivative (Table II)
Transaction date
Feb 13, 2026
Transaction code
A
Shares / units
1,142
Price per share
$0.00
Acquired / disposed
Acquired (A)
Shares owned after
2,212
Ownership form
Direct
Amendment
No
Footnotes from the filing
Each performance stock unit represents a contingent right to receive one share of Chemed Capital Stock
Performance stock units vest based on the extent to which the Company achieves certain performance targets over a performance period of January 1, 2026 to December 31, 2028. The determination of the performance level is to be made by March 15, 2029 and earned shares to be delivered thereafter.